Literature DB >> 31057013

Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy.

Sara Mariotto1, Cristina Tecchio2, Marco Sorio2, Laura Bertolasi1, Marco Turatti1, Maria C Tozzi1, Fabio Benedetti2, Guido Cavaletti3, Salvatore Monaco1, Sergio Ferrari1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31057013     DOI: 10.1080/10428194.2019.1605068

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  2 in total

Review 1.  Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy.

Authors:  Roser Velasco; Eva Domingo-Domenech; Anna Sureda
Journal:  Cancers (Basel)       Date:  2021-12-05       Impact factor: 6.639

2.  Evaluation of neuropathic pain with diverse pathophysiologies in childhood cancers.

Authors:  Hilal Susam Sen; Tugce Aksu Uzunhan
Journal:  North Clin Istanb       Date:  2022-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.